Reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography in hypervascular spinal metastases prior embolization
- 15 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 31 (7), 4690-4699
- https://doi.org/10.1007/s00330-020-07654-3
Abstract
Objectives Preoperative embolization of hypervascular spinal metastases (HSM) is efficient to reduce perioperative bleeding. However, intra-arterial digital subtraction angiography (IA-DSA) must confirm the hypervascular nature and rule out spinal cord arterial feeders. This study aimed to evaluate the reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography (TR-CE-MRA) in assessing HSM prior to embolization. Methods All consecutive patients referred for preoperative embolization of an HSM were prospectively included. TR-CE-MRA sequences and selective IA-DSA were performed prior to embolization. Two readers independently reviewed imaging data to grade tumor vascularity (using a 3-grade and a dichotomized “yes vs no” scale) and identify the arterial supply of the spinal cord. Interobserver and intermodality agreements were estimated using kappa statistics. Results Thirty patients included between 2016 and 2019 were assessed for 55 levels. Interobserver agreement was moderate (κ = 0.52; 95% CI [0.09–0.81]) for TR-CE-MRA. Intermodality agreement between TR-CE-MRA and IA-DSA was good (κ = 0.74; 95% CI [0.37–1.00]). TR-CE-MRA had a sensitivity of 97.9%, a specificity of 71.4%, a positive predictive value of 95.9%, a negative predictive value of 83.3%, and an overall accuracy of 94.6%, for differentiating hypervascular from non-hypervascular SM. The arterial supply of the spine was assessable in 2/30 (6.7%) cases with no interobserver agreement (κ < 0). Conclusions TR-CE-MRA can reliably differentiate hypervascular from non-hypervascular SM and thereby avoid futile IA-DSAs. However, TR-CE-MRA was not able to evaluate the vascular supply of the spinal cord at the target levels, thus limiting its scope as a pretherapeutic assessment tool. Key Points • TR-CE-MRA aids in distinguishing hypervascular from non-hypervascular spinal metastases. • TR-CE-MRA could avoid one-quarter of patients referred for HSM embolization to undergo futile conventional angiography. • TR-CE-MRA’s spatial resolution is insufficient to replace IA-DSA in the pretherapeutic assessment of the spinal cord vascular anatomy.This publication has 21 references indexed in Scilit:
- An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportThe Lancet Oncology, 2017
- Time-resolved magnetic resonance angiography (MRA) at 3.0 Tesla for evaluation of hemodynamic characteristics of vascular malformations: description of distinct subgroupsEuropean Radiology, 2016
- Preoperative Embolization of Spinal Tumors: A Systematic Review and Meta-AnalysisWorld Neurosurgery, 2015
- Risk factors for major complications in surgery for hypervascular spinal tumors: an analysis of 120 cases with adjuvant preoperative embolizationEuropean Spine Journal, 2015
- MRI and MRA of spinal cord arteriovenous shuntsJournal of Magnetic Resonance Imaging, 2014
- Characterizing Hypervascular and Hypovascular Metastases and Normal Bone Marrow of the Spine Using Dynamic Contrast-Enhanced MR ImagingAmerican Journal of Neuroradiology, 2012
- Estimated number of prevalent cases of metastatic bone disease in the US adult populationClinical Epidemiology, 2012
- Evaluation of Brain and Head and Neck Tumors with 4D Contrast-Enhanced MR Angiography at 3TAmerican Journal of Neuroradiology, 2011
- Preoperative transarterial embolization of vertebral metastasesEuropean Spine Journal, 2004
- Time‐resolved contrast‐enhanced 3D MR angiographyMagnetic Resonance in Medicine, 1996